<p>TransMedics Group, Inc.（纳斯达克代码：TMDX - 获取免费报告）周一股价上涨了 7.1%。该公司股价最高达到 68.38 美元，最后交易价格为 67.7150 美元。在午盘交易中，共交易了 214,221 股，较平均交易量 1,057,757 股下降了 80%。该股票此前收盘价为 63.20 美元。</p>
<p>获取 <strong>TransMedics Group</strong> 的提醒：</p>
<h2>华尔街分析师观点</h2>
<ul>
<li>中型股奇迹：三只在 5 月超越销售预期的股票</li>
</ul>
<p>多家研究公司已对 TMDX 发布了报告。Canaccord Genuity Group 将 TransMedics Group 的目标价从 152.00 美元下调至 124.00 美元，并在 5 月 6 日的报告中给予该股票 “买入” 评级。TD Cowen 将 TransMedics Group 的目标价从 190.00 美元下调至 120.00 美元，并在 5 月 6 日的研究报告中给予该股票 “买入” 评级。Stifel Nicolaus 将 TransMedics Group 的目标价从 130.00 美元下调至 85.00 美元，并在 5 月 6 日的研究报告中给予该股票 “持有” 评级。Needham &amp; Company LLC 将 TransMedics Group 的目标价从 174.00 美元下调至 142.00 美元，并在 5 月 6 日的报告中给予该公司 “买入” 评级。最后，Wall Street Zen 在 5 月 9 日的研究报告中将 TransMedics Group 的评级从 “持有” 下调至 “卖出”。六位投资分析师对该股票给予了 “买入” 评级，六位分析师给予了 “持有” 评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “适度买入”，平均目标价为 135.00 美元。</p>
<p><strong>查看我们对 TMDX 的最新分析</strong></p>
<h2>TransMedics Group 股票表现</h2>
<ul>
<li>三只在 2025 年表现优异的医疗科技股票</li>
</ul>
<p>该股票的 50 日简单移动平均线为 104.66 美元，200 日简单移动平均线为 122.77 美元。该公司的市值为 23.3 亿美元，市盈率为 15.33，贝塔值为 2.07。该公司的债务与股本比率为 1.70，速动比率为 6.19，流动比率为 6.74。</p>
<p>TransMedics Group（纳斯达克代码：TMDX - 获取免费报告）最近于 5 月 5 日发布了其财报。该公司报告季度每股收益为 0.30 美元，低于分析师一致预期的 0.62 美元，差距为 0.32 美元。TransMedics Group 的股本回报率为 22.38%，净利润率为 27.04%。该公司季度收入为 1.7393 亿美元，而分析师预期为 1.7444 亿美元。在去年同期，该公司每股收益为 0.70 美元。该公司的季度收入同比增长 21.2%。整体来看，研究分析师预计 TransMedics Group, Inc.在当前财年将发布 1.98 美元的每股收益。</p>
<h2>内部人士下注</h2>
<ul>
<li>三只高增长股票，交易者喜爱，投资者应关注</li>
</ul>
<p>在相关消息中，内部人士 Anil P. Ranganath 于 3 月 2 日星期一出售了 864 股公司的股票，交易价格为 139.12 美元，总价值为 120,199.68 美元。交易完成后，该内部人士直接持有 13,091 股公司股票，价值为 1,821,219.92 美元。这代表其持股比例下降了 6.19%。该交易已在向 SEC 提交的文件中披露，文件可通过此超链接获取。此外，首席财务官 Gerardo Hernandez 于 3 月 4 日星期三出售了 7,236 股股票，交易价格为 147.21 美元，总交易额为 1,065,211.56 美元。交易完成后，首席财务官持有 14,689 股公司股票，价值为 2,162,367.69 美元。这代表其持股比例下降了 33.00%。该交易的披露信息可在 SEC 文件中找到。在上个季度，内部人士共出售了价值 2,353,002 美元的 16,205 股公司股票。目前，内部人士持有该公司 6.90% 的股票。</p>
<h2>对 TransMedics Group 的对冲基金观点</h2>
<p>几家大型投资者最近买入和卖出了 TMDX 的股票。Quantinno Capital Management LP 在第一季度将其在 TransMedics Group 的持股增加了 197.9%。Quantinno Capital Management LP 现在拥有 8,059 股公司股票，价值为 801,000 美元，此前在上个季度又购买了 5,354 股。Beaconlight Capital LLC 在第一季度将其在 TransMedics Group 的持股增加了 44.8%。Beaconlight Capital LLC 现在拥有 42,478 股公司股票，价值为 4,223,000 美元，此前在上个季度又购买了 13,134 股。俄亥俄州公共雇员退休系统在第一季度将其在 TransMedics Group 的持股增加了 8.1%。俄亥俄州公共雇员退休系统现在拥有 14,666 股公司股票，价值为 1,458,000 美元，此前在该期间又购买了 1,094 股。Keebeck Wealth Management 在第一季度将其在 TransMedics Group 的持股增加了 12.4%。Keebeck Wealth Management 现在拥有 5,175 股公司股票，价值为 514,000 美元，此前在上个季度又购买了 572 股。最后，Sei Investments Co.在第一季度将其在 TransMedics Group 的持股增加了 25.9%。Sei Investments Co.现在拥有 69,629 股公司股票，价值为 6,922,000 美元，此前在上个季度又购买了 14,338 股。机构投资者和对冲基金持有该公司 99.67% 的股票。</p>
<h2>TransMedics Group 公司简介</h2>
<p>（获取免费报告）</p>
<p>TransMedics Group, Inc 是一家总部位于马萨诸塞州安多佛的医疗设备公司，专注于先进的器官保存和运输系统，以用于移植。该公司的旗舰技术——器官护理系统（OCS），在运输过程中保持供体器官处于接近生理状态的温暖跳动状态，旨在延长保存时间并改善移植后的结果。TransMedics 的解决方案满足了移植领域的关键需求，通过减少缺血损伤和扩大供体器官池来解决问题。</p>
<p>TransMedics 目前市场上有两个可商业化的 OCS 平台。</p>
<h2>了解更多</h2>
<ul>
<li>五只我们认为比 TransMedics Group 更好的股票</li>
<li>为什么 Applied Optoelectronics 的股票可能接近转折点</li>
<li>从高收益到高增长：3 只提升股息的股票</li>
<li>Everspin Technologies 会是下一个 AI 边缘突破吗？</li>
<li>5 只机器人股票值得关注，因为物理 AI 正在蓬勃发展</li>
</ul>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在 TransMedics Group 吗？</h2>
<p>在考虑 TransMedics Group 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 TransMedics Group 并不在名单上。</p>
<p>虽然 TransMedics Group 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

TMDX

标普健康医疗设备 ETF - SPDR

医药突破 ETF - ALPS

美国医药设备 ETF - iShares

<p>TransMedics Group（纳斯达克代码：TMDX）股价上涨 7.1%，至 67.71 美元，尽管交易量显著下降。分析师的评级不一，目标价格范围从 85 美元到 190 美元不等。该公司报告第一季度每股收益为 0.30 美元，低于预期，但收入同比增长 21.2%。内部人士最近出售了股份，而对冲基金则增加了对该公司的持股</p>

<p>Shares of TransMedics Group, Inc. (NASDAQ:TMDX - Get Free Report) traded up 7.1% on Monday . The company traded as high as $68.38 and last traded at $67.7150. 214,221 shares were traded during mid-day trading, a decline of 80% from the average session volume of 1,057,757 shares. The stock had previously closed at $63.20.</p>
<div class="lb-trans"><p>TransMedics Group, Inc.（纳斯达克代码：TMDX - 获取免费报告）周一股价上涨了 7.1%。该公司股价最高达到 68.38 美元，最后交易价格为 67.7150 美元。在午盘交易中，共交易了 214,221 股，较平均交易量 1,057,757 股下降了 80%。该股票此前收盘价为 63.20 美元。</p>
</div><p>Get <strong>TransMedics Group</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>TransMedics Group</strong> 的提醒：</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><ul>
<li>Mid-Cap Marvels: 3 Stocks That Crushed Sales Estimates in May</li>
</ul>
<div class="lb-trans"><ul>
<li>中型股奇迹：三只在 5 月超越销售预期的股票</li>
</ul>
</div><p>A number of research firms have issued reports on TMDX. Canaccord Genuity Group reduced their target price on shares of TransMedics Group from $152.00 to $124.00 and set a &#34;buy&#34; rating on the stock in a report on Wednesday, May 6th. TD Cowen cut their price objective on TransMedics Group from $190.00 to $120.00 and set a &#34;buy&#34; rating on the stock in a research report on Wednesday, May 6th. Stifel Nicolaus reduced their price objective on TransMedics Group from $130.00 to $85.00 and set a &#34;hold&#34; rating on the stock in a research note on Wednesday, May 6th. Needham &amp; Company LLC decreased their target price on TransMedics Group from $174.00 to $142.00 and set a &#34;buy&#34; rating for the company in a report on Wednesday, May 6th. Finally, Wall Street Zen cut TransMedics Group from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a research note on Saturday, May 9th. Six investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of &#34;Moderate Buy&#34; and an average price target of $135.00.</p>
<div class="lb-trans"><p>多家研究公司已对 TMDX 发布了报告。Canaccord Genuity Group 将 TransMedics Group 的目标价从 152.00 美元下调至 124.00 美元，并在 5 月 6 日的报告中给予该股票 “买入” 评级。TD Cowen 将 TransMedics Group 的目标价从 190.00 美元下调至 120.00 美元，并在 5 月 6 日的研究报告中给予该股票 “买入” 评级。Stifel Nicolaus 将 TransMedics Group 的目标价从 130.00 美元下调至 85.00 美元，并在 5 月 6 日的研究报告中给予该股票 “持有” 评级。Needham &amp; Company LLC 将 TransMedics Group 的目标价从 174.00 美元下调至 142.00 美元，并在 5 月 6 日的报告中给予该公司 “买入” 评级。最后，Wall Street Zen 在 5 月 9 日的研究报告中将 TransMedics Group 的评级从 “持有” 下调至 “卖出”。六位投资分析师对该股票给予了 “买入” 评级，六位分析师给予了 “持有” 评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “适度买入”，平均目标价为 135.00 美元。</p>
</div><p><strong>View Our Latest Analysis on TMDX</strong></p>
<div class="lb-trans"><p><strong>查看我们对 TMDX 的最新分析</strong></p>
</div><h2>TransMedics Group Stock Performance</h2>
<div class="lb-trans"><h2>TransMedics Group 股票表现</h2>
</div><ul>
<li>3 Medical Technology Stocks Outperforming in 2025</li>
</ul>
<div class="lb-trans"><ul>
<li>三只在 2025 年表现优异的医疗科技股票</li>
</ul>
</div><p>The stock's 50-day simple moving average is $104.66 and its 200 day simple moving average is $122.77. The company has a market capitalization of $2.33 billion, a PE ratio of 15.33 and a beta of 2.07. The company has a debt-to-equity ratio of 1.70, a quick ratio of 6.19 and a current ratio of 6.74.</p>
<div class="lb-trans"><p>该股票的 50 日简单移动平均线为 104.66 美元，200 日简单移动平均线为 122.77 美元。该公司的市值为 23.3 亿美元，市盈率为 15.33，贝塔值为 2.07。该公司的债务与股本比率为 1.70，速动比率为 6.19，流动比率为 6.74。</p>
</div><p>TransMedics Group (NASDAQ:TMDX - Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $0.30 EPS for the quarter, missing analysts' consensus estimates of $0.62 by ($0.32). TransMedics Group had a return on equity of 22.38% and a net margin of 27.04%.The firm had revenue of $173.93 million for the quarter, compared to analyst estimates of $174.44 million. During the same quarter in the previous year, the firm posted $0.70 EPS. The business's revenue for the quarter was up 21.2% on a year-over-year basis. As a group, research analysts expect that TransMedics Group, Inc. will post 1.98 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>TransMedics Group（纳斯达克代码：TMDX - 获取免费报告）最近于 5 月 5 日发布了其财报。该公司报告季度每股收益为 0.30 美元，低于分析师一致预期的 0.62 美元，差距为 0.32 美元。TransMedics Group 的股本回报率为 22.38%，净利润率为 27.04%。该公司季度收入为 1.7393 亿美元，而分析师预期为 1.7444 亿美元。在去年同期，该公司每股收益为 0.70 美元。该公司的季度收入同比增长 21.2%。整体来看，研究分析师预计 TransMedics Group, Inc.在当前财年将发布 1.98 美元的每股收益。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>内部人士下注</h2>
</div><ul>
<li>3 High-Growth Stocks Traders Love and Investors Should Watch</li>
</ul>
<div class="lb-trans"><ul>
<li>三只高增长股票，交易者喜爱，投资者应关注</li>
</ul>
</div><p>In related news, insider Anil P. Ranganath sold 864 shares of the company's stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $139.12, for a total value of $120,199.68. Following the completion of the transaction, the insider directly owned 13,091 shares of the company's stock, valued at $1,821,219.92. This represents a 6.19% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Gerardo Hernandez sold 7,236 shares of the stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $147.21, for a total transaction of $1,065,211.56. Following the completion of the transaction, the chief financial officer owned 14,689 shares in the company, valued at $2,162,367.69. This represents a 33.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 16,205 shares of company stock worth $2,353,002. 6.90% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在相关消息中，内部人士 Anil P. Ranganath 于 3 月 2 日星期一出售了 864 股公司的股票，交易价格为 139.12 美元，总价值为 120,199.68 美元。交易完成后，该内部人士直接持有 13,091 股公司股票，价值为 1,821,219.92 美元。这代表其持股比例下降了 6.19%。该交易已在向 SEC 提交的文件中披露，文件可通过此超链接获取。此外，首席财务官 Gerardo Hernandez 于 3 月 4 日星期三出售了 7,236 股股票，交易价格为 147.21 美元，总交易额为 1,065,211.56 美元。交易完成后，首席财务官持有 14,689 股公司股票，价值为 2,162,367.69 美元。这代表其持股比例下降了 33.00%。该交易的披露信息可在 SEC 文件中找到。在上个季度，内部人士共出售了价值 2,353,002 美元的 16,205 股公司股票。目前，内部人士持有该公司 6.90% 的股票。</p>
</div><h2>Hedge Funds Weigh In On TransMedics Group</h2>
<div class="lb-trans"><h2>对 TransMedics Group 的对冲基金观点</h2>
</div><p>Several large investors have recently bought and sold shares of TMDX. Quantinno Capital Management LP grew its holdings in shares of TransMedics Group by 197.9% during the first quarter. Quantinno Capital Management LP now owns 8,059 shares of the company's stock worth $801,000 after purchasing an additional 5,354 shares during the last quarter. Beaconlight Capital LLC lifted its holdings in shares of TransMedics Group by 44.8% in the 1st quarter. Beaconlight Capital LLC now owns 42,478 shares of the company's stock valued at $4,223,000 after purchasing an additional 13,134 shares during the last quarter. Public Employees Retirement System of Ohio boosted its position in shares of TransMedics Group by 8.1% in the 1st quarter. Public Employees Retirement System of Ohio now owns 14,666 shares of the company's stock valued at $1,458,000 after purchasing an additional 1,094 shares during the period. Keebeck Wealth Management grew its stake in TransMedics Group by 12.4% during the 1st quarter. Keebeck Wealth Management now owns 5,175 shares of the company's stock worth $514,000 after buying an additional 572 shares during the last quarter. Finally, Sei Investments Co. grew its stake in TransMedics Group by 25.9% during the 1st quarter. Sei Investments Co. now owns 69,629 shares of the company's stock worth $6,922,000 after buying an additional 14,338 shares during the last quarter. Institutional investors and hedge funds own 99.67% of the company's stock.</p>
<div class="lb-trans"><p>几家大型投资者最近买入和卖出了 TMDX 的股票。Quantinno Capital Management LP 在第一季度将其在 TransMedics Group 的持股增加了 197.9%。Quantinno Capital Management LP 现在拥有 8,059 股公司股票，价值为 801,000 美元，此前在上个季度又购买了 5,354 股。Beaconlight Capital LLC 在第一季度将其在 TransMedics Group 的持股增加了 44.8%。Beaconlight Capital LLC 现在拥有 42,478 股公司股票，价值为 4,223,000 美元，此前在上个季度又购买了 13,134 股。俄亥俄州公共雇员退休系统在第一季度将其在 TransMedics Group 的持股增加了 8.1%。俄亥俄州公共雇员退休系统现在拥有 14,666 股公司股票，价值为 1,458,000 美元，此前在该期间又购买了 1,094 股。Keebeck Wealth Management 在第一季度将其在 TransMedics Group 的持股增加了 12.4%。Keebeck Wealth Management 现在拥有 5,175 股公司股票，价值为 514,000 美元，此前在上个季度又购买了 572 股。最后，Sei Investments Co.在第一季度将其在 TransMedics Group 的持股增加了 25.9%。Sei Investments Co.现在拥有 69,629 股公司股票，价值为 6,922,000 美元，此前在上个季度又购买了 14,338 股。机构投资者和对冲基金持有该公司 99.67% 的股票。</p>
</div><h2>TransMedics Group Company Profile</h2>
<div class="lb-trans"><h2>TransMedics Group 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>TransMedics Group, Inc is a medical device company headquartered in Andover, Massachusetts, that specializes in advanced organ preservation and transport systems for transplantation. The company's flagship technology, the Organ Care System (OCS), maintains donor organs in a near-physiologic, warm, beating state during transportation, with the aim of extending preservation times and improving post‐transplant outcomes. TransMedics' solutions address a critical need in transplantation by reducing ischemic injury and expanding the donor organ pool.</p>
<div class="lb-trans"><p>TransMedics Group, Inc 是一家总部位于马萨诸塞州安多佛的医疗设备公司，专注于先进的器官保存和运输系统，以用于移植。该公司的旗舰技术——器官护理系统（OCS），在运输过程中保持供体器官处于接近生理状态的温暖跳动状态，旨在延长保存时间并改善移植后的结果。TransMedics 的解决方案满足了移植领域的关键需求，通过减少缺血损伤和扩大供体器官池来解决问题。</p>
</div><p>TransMedics currently markets two commercially available OCS platforms.</p>
<div class="lb-trans"><p>TransMedics 目前市场上有两个可商业化的 OCS 平台。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than TransMedics Group</li>
<li>Why Applied Optoelectronics Stock May Be Near a Turning Point</li>
<li>From High-Yield to High-Growth: 3 Stocks Boosting Dividends</li>
<li>Is Everspin Technologies the Next AI Edge Breakout?</li>
<li>5 Robotics Stocks to Watch as Physical AI Builds Momentum</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们认为比 TransMedics Group 更好的股票</li>
<li>为什么 Applied Optoelectronics 的股票可能接近转折点</li>
<li>从高收益到高增长：3 只提升股息的股票</li>
<li>Everspin Technologies 会是下一个 AI 边缘突破吗？</li>
<li>5 只机器人股票值得关注，因为物理 AI 正在蓬勃发展</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，旨在为读者提供最快的报道和公正的覆盖。如对本故事有任何问题或意见，请发送邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in TransMedics Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 TransMedics Group 吗？</h2>
</div><p>Before you consider TransMedics Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 TransMedics Group 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TransMedics Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 TransMedics Group 并不在名单上。</p>
</div><p>While TransMedics Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 TransMedics Group 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

TransMedics Group（NASDAQ:TMDX）股价上涨 7.1% - 事情经过